Chargement en cours...

Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals

INTRODUCTION: The FDA issued a warning following 24 cases of HBV reactivation during DAA therapy for HCV, including individuals with inactive, occult and past HBV infection. Clinical presentations ranged from asymptomatic fluctuations in HBV DNA to fulminant hepatic failure, liver transplantation an...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Expert Opin Drug Saf
Auteurs principaux: Holmes, Jacinta A., Yu, Ming-Lung, Chung, Raymond T.
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589072/
https://ncbi.nlm.nih.gov/pubmed/28471314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2017.1325869
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!